Stocks/Funds/CIK 1053906

Artal Group S.A.

long-term holderconcentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 1053906
Assets
$1.01B
+14.3% YoY
Holdings
2
Lifetime alpha vs market
-15.44% annual
Average hold time
6.8 yr
median 6.8 yr

Quarterly history

Cum return -22% vs S&P +52% · α -74% lifetimeAUM $1.0B · peak $6.8BFlow $29M (+4%)2016-062017-122019-062020-122022-062023-122025-062026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
-1.03%
trims when stocks drop
when a holding falls −10%+
Middle response
-6.67%
baseline attrition
Rally response
-7.33%
trims into rallies
when a holding rises +10%+

Top positions · 2

Ticker$ value% portYoYHold time
CAVACAVA Group, Inc.$769M76.1%-6.4%3.0 yr
LXRXLexicon Pharmaceuticals,$241M23.9%+238.5%10.5 yr

Portfolio composition (YoY)

Industry mix
Restaurants76.1%-16.8pp$769M
Biotechnology23.9%+16.8pp$241M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %
LXRX$63M+0.15B238.5%
CAVA$822M-0.05B-6.4%

Losers

TickerPrev $PnLYoY %
CAVA$822M-0.05B-6.4%

Top buys this quarter · 1

LXRX Lexicon Pharmaceuticals, Inc.+$29M

Top sells this quarter · 0

No sells this quarter

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$1.01B2+11.00%+17.59%-6.59%+0.03B
2025-12-31$715M2-39.08%+17.72%-56.80%-0.00B
2025-09-30$758M2-43.69%+17.52%-61.20%-0.00B
2025-06-30$930M2-16.10%+14.94%-31.05%+0.00B
2025-03-31$884M2-13.95%+8.30%-22.26%-0.00B
2024-12-31$1.17B2+60.22%+24.89%+35.33%-0.90B
2024-09-30$2.38B2+155.98%+36.04%+119.94%-2.35B
2024-06-30$3.89B109+58.99%+24.49%+34.50%-0.29B
2024-03-31$3.88B107+87.01%+29.62%+57.39%-0.24B
2023-12-31$2.93B91+40.40%+26.18%+14.23%-0.26B
2023-09-30$2.29B101-2.77%+21.57%-24.33%-0.06B
2023-06-30$3.12B114-13.72%+19.42%-33.14%+0.99B
2023-03-31$1.68B118-56.45%-7.82%-48.63%-0.13B
2022-12-31$1.72B124-3.60%+7.56%-11.16%-0.12B
2022-09-30$1.92B130-33.03%-4.93%-28.10%+0.71B
2022-06-30$1.80B132-35.99%-16.11%-19.88%+0.28B